The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer

Journal of the American College of Surgeons

Volumn 185, Issue 1, 1997, Pages 60-64

  Wolf, Ronald F ^a   Cohen, Alfred M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER RECURRENCE; COLORECTAL CANCER; COLORECTAL SURGERY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0030922623     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(97)00011-2     Document Type: Article

References (21)

1. Kievit, J, and Van de Velde CJH. Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. Cancer 1990;65:2580-7.
2. Moertel, CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, and Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270(8):943-7.
3. Virgo KS, Vernava AM. Longo WE, McKirgan LW, and Johnson FE. Cost of patient follow-up after potentially currative colorectal cancer treatment. JAMA 1995;(23):1837-41.
4. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med 1986;104:66-73.
5. Attiyeh FF, and Stearns MWJ. Second-look laparotomy based on CEA elevations in colorectal cancer. Cancer 1981;47:2119-25.
6. Minton JP, Hoehn JL, Gerber DM, Horsley S, Connolly DP, Salwan F, et al. Results of a 400-patient carcinoernbryonic antigen second-look cancer study. Cancer 1985;55:1284-90.
7. Steele G Jr., Bleday R, Mayer RJ, Lindblad A, Petrelli N, and Weaver D. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 1991;9(7): 1105-12.
8. Sugarbaker PH, Gianola FJ, Dwyer A, and Neuman NR. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 1987;100(2):79-87.
9. Sandler RS, Freund DA, Herbst CAJ, and Sandler DP. Cost effectiveness of postoperative carcinoernbryonic antigen monitoring in colorectal cancer. Cancer 1984;53:193-8.
10. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Cancer AJ Co. Manual for staging of cancer, 4th ed. Philadelphia: Lippincott, 1992.
11. Peto R, and Peto J. Asymptomatically efficient rank invariant test procedures (with discussion). J Roy Stat Soc 1972;135(Series A):185-206.
12. Kaplan EL, and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
13. BoeyJ, Cheung JC, Lai CK, and WongJ. A prospective evaluation of serum carcinoernbryonic antigen levels in the management of colorectal carcinoma. World J Surg 1994;8:279-86.
14. Wang JY, Tang R, and Chiang JM. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum 1994;37(3):272-7.
15. Staab JJ, Anderer FA, Stumpg E, and Fischer R. Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastro-intestinal cancer. Am J Surg 1978;136:322-27.
16. Wanebo JJ, Llaneras M, Martin T, and Kaiser D. Prospective monitoring trial for carcinoma of colon and rectum after surgical resection. Surg Gyn Obstet 1989;169(6):497.
17. Steele G Jr. Follow-up plans after treatment of primary colon and rectum cancer. World J Surg 1991;15(5):583-8.
18. Dentsman F, Rosen L, Khubchandani IT, Sheets JA, Stasik JJ, and Riether RD. Comparing predictive decision rules in postoperative CEA monitoring. Cancer 1986;58:2089-95.
19. Steele G Jr., Ellenberg S, Ramming K, O'Connell M, Moertel C, Lessner H, et al. CEA monitoring among patients in multiinstitutional adjuvant G. I. therapy protocols. Ann Surg 1982; 196(2):162-9.
20. Sardi A, Minton JP, Nieroda C, Sickle-Santanello B, Young D. and Martin EW Multiple reoperations in recurrent colorectal carcinoma. Cancer 1988;61:1913-9.
21. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts JM, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994;37:875-81.